Cohu: Earnings Growth Is Not Keeping Up With Increased Valuations

The latest report included an upgraded FY2026 outlook and strong top- and bottom-line growth, but earnings are still not expanding fast enough to justify the stock's elevated valuation. After a sharp rally in 2026, the article argues the shares may now be priced ahead of fundamentals. Overall tone is mixed: improving operating performance, but valuation risk remains a key overhang.

Analysis

The key tension is not operating momentum but duration: when a stock rerates faster than the earnings base, the burden shifts from execution to proof. That usually creates a fragile setup where the next 1-2 quarters matter less for absolute results than for whether management can keep adding to guidance without needing multiple expansion to do the heavy lifting.

Second-order, the winners are likely not the company itself but peers with similar growth profiles trading at lower forward multiples, especially if investors start rotating from “best-looking chart” names into cheaper compounders. Suppliers and adjacent vendors can also see a short-lived halo if the market extrapolates the upgraded outlook, but that effect tends to fade once the street recalibrates to a more realistic terminal margin/earnings path.

The main downside catalyst is not a weak quarter; it is simply a quarter that is merely good instead of great. If earnings growth decelerates while the stock remains elevated, multiple compression can happen quickly over days to weeks, particularly if sell-side estimates stop moving higher. A second risk is that a strong technical trend invites crowded long positioning, which raises the probability of an air pocket on any guidance miss or softer backlog commentary.

Contrarianly, the market may be underpricing the difference between revenue growth and earnings quality. If the latest gains came with improving margins and a cleaner outlook, this could still be early-cycle rather than late-cycle, but the bar has moved to where any incremental disappointment matters disproportionately. The best read is that the stock may be overextended in the short run even if the business remains fundamentally sound over 12 months.

Key Decisions for Investors

• Fade strength tactically: initiate a small short or put spread on the name after extended post-earnings momentum, targeting a 1-2 month horizon; risk/reward favors a mean reversion trade if the stock is already pricing in perfection.
• If liquid enough, pair long a cheaper peer with similar fundamentals versus short the elevated multiple winner; aim for relative valuation compression over 1-3 quarters rather than outright direction.
• Use any near-term pullback to reassess for a long only if forward earnings revisions continue rising; otherwise avoid chasing here, as upside likely requires multiple expansion rather than fundamentals.
• For holders, monetize part of the position into strength and keep a trailing stop under the prior breakout area; the stock is more vulnerable to a guidance disappointment than to a collapse in fundamentals.